Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Yirdaw, Kesetebirhan Delele ^a   Jerene, Degu ^a   Gashu, Zewdu ^a   Edginton, M E ^b   Kumar, Ajay M V ^c   Letamo, Yohannes ^d   Feleke, Beniam ^e   Teklu, Alula M ^a   Zewdu, Solomon ^f   Weiss, Bill ^f   Ruff, Andrea ^f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Center for Operations Research   (France)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^d Health Research and Technology Transfer Support Process Southern Nations Nationalities and People's Region Health Bureau   (Ethiopia)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIVIRAL THERAPY; ARTICLE; CHILD; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ETHIOPIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; RETROSPECTIVE STUDY; RISK REDUCTION; TUBERCULOSIS; COMPLICATION; HIV INFECTIONS; MIDDLE AGED; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ETHIOPIA; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; ISONIAZID; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TUBERCULOSIS; YOUNG ADULT;

EID: 84905668722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104557     Document Type: Article

References (24)

1. World Health Organisation (2013) Global Tuberculosis Report 2013. Geneva, Switzerland.
2. Federal Ministry of Health Ethiopian Health and Nutrition Research Institute (2011) First Ethiopian national population based TB prevalence survey. Ethiopia.
3. Ethiopian Statistical Agency (2011) Demographic and health survey.
4. World Health Organisation (2011) Guideline for Intensified TB case-findings and isoniazid Preventive Therapy for HIV positive patients in resource constrained settings. Geneva, Switzerland.
5. Golub JE, Pronyk P, Mohapi L, Thsabangu N, Moshabela M, et al. (2009) Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS 23: 631-636.
6. Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, et al. (2007) The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 21: 1441-1448. (Pubitemid 46988004)
7. Gupta A, Wood R, Kaplan R, Bekker L-G, Lawn SD (2012) Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One 7: e34156.
8. Kibret KT, Yalew AW, Belaineh BG, Asres MM (2013) Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study. PLoS One 8: e64488.
9. Ethiopian Population Census Commission (2008) Summary and Statistical Report of the 2007 Population and Housing Census.
10. Federal HIV/AIDS Prevention and Control Office & Federal Ministry of Health (2008) Guideline for Antiretroviral Therapy, Ethiopia.
11. Federal Ministry of Health (2012) Guidelines for clinical and programmatic management of TB, Leprosy and TB/HIV in Ethiopia. Addis Ababa, Ethiopia.
12. Federal Ministry of Health (2010) Health management information system (HMIS) participants' handout & instruments. Ethiopia.
13. World Health Organisation (2010) Treatment of tuberculosis guideline 4th edition. 2010. Geneva, Switzerland.
14. Jerene D, Næss A, Lindtjørn B (2006) Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Research and Therapy 3: 10.
15. Tegbaru B, Wolday D, Messele T, Legesse M, Mekonnen Y, et al. (2006) Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia. Clinical and Vaccine immunology 13: 784-789.
16. Getahun H, Granich R, Sculier D, Gunneberg C, Blanc L, et al. (2010) Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS 24: S57-65.
17. Federal Ministry of Health (2004) National TB/HIV Surveillance Progress Report and Findings. Ethiopia.
18. Federal HIV/AIDS Prevention and Control Office & Federal Ministry of Health (2012) Country Progress Report on HIV/AIDS Response. Ethiopia.
19. Lester R, Hamilton R, Charalambous S, Dwadwa T, Chandler C, et al. (2010) Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS 24.
20. Kabali C, von Reyn C, Brooks D, Waddell R, Mtei L, et al. (2011) Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania. The International Journal of Tuberculosis and Lung Disease 15: 1515-1522.
21. Granich R, Gupta S, B Suthar A, Smyth C, Hoos D, et al. (2011) Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Current HIV research 9: 446-469
22. Auld AF, Mbofana F, Shiraishi RW, Alfredo C, Sanchez M, et al. (2013) Incidence and Determinants of Tuberculosis among Adults Initiating Antiretroviral Therapy-Mozambique, 2004-2008. PloS one 8: e54665.
23. Chehab JC, Vilakazi-Nhlapo AK, Vranken P, Peters A, Klausner JD (2013) Current Integration of Tuberculosis (TB) and HIV Services in South Africa, 2011. PloS one 8: e57791.
24. Durovni B, Cavalcante SC, Saraceni V, Vellozo V, Israel G, et al. (2010) The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS (London, England) 24: S49.